Oral antihistamine therapy influences plasma tryptase levels in adult atopic dermatitis.

[1]  S. Ständer,et al.  Neurophysiological evidence for altered sensory function caused by storage of hydroxyethyl starch in cutaneous nerve fibres , 2005, The British journal of dermatology.

[2]  P. Kam,et al.  Mast cell tryptase: a review of its physiology and clinical significance , 2004, Anaesthesia.

[3]  M. Schmelz,et al.  Painful stimuli evoke itch in patients with chronic pruritus , 2004, Neurology.

[4]  T. Luger,et al.  Neurophysiology of pruritus: cutaneous elicitation of itch. , 2003, Archives of dermatology.

[5]  Sonja Ständer,et al.  Modern aspects of cutaneous neurogenic inflammation. , 2003, Archives of dermatology.

[6]  T. Kawakami,et al.  Effective treatment of pruritus in atopic dermatitis using H1 antihistamines (second-generation antihistamines): changes in blood histamine and tryptase levels. , 2003, Journal of dermatological science.

[7]  Thomas A. Luger,et al.  Proteinase-Activated Receptor-2 Mediates Itch: A Novel Pathway for Pruritus in Human Skin , 2003, The Journal of Neuroscience.

[8]  T. Tango,et al.  Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1‐week randomized, multicentre, double‐blind, placebo‐controlled, parallel‐group study , 2003, The British journal of dermatology.

[9]  Y. Aragane,et al.  Quantitative analysis of bikunin-laden mast cells in follicular eruptions and chronic skin lesions of atopic dermatitis , 2002, Archives of Dermatological Research.

[10]  T. Tango,et al.  Review of fexofenadine in the treatment of chronic idiopathic urticaria , 2002, International journal of dermatology.

[11]  F. Simons,et al.  Skin concentrations of H1-receptor antagonists. , 2001, The Journal of allergy and clinical immunology.

[12]  F. McGlone,et al.  Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study , 2000, The British journal of dermatology.

[13]  H. Nelson,et al.  Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[14]  A. Kaplan,et al.  A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. , 1999, The Journal of allergy and clinical immunology.

[15]  D. Bernstein,et al.  Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis. , 1997, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[16]  F. B. Sørensen,et al.  Mast cells and atopic dermatitis. Stereological quantification of mast cells in atopic dermatitis and normal human skin , 1997, Archives of Dermatological Research.

[17]  R. Graham-Brown.  Managing adults with atopic dermatitis. , 1996, Dermatologic clinics.

[18]  A. Halbert.  The practical management of atopic dermatitis in children. , 1996, Pediatric annals.

[19]  D. Leung,et al.  Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. , 1995, The Journal of allergy and clinical immunology.

[20]  S. Holgate,et al.  Granulocyte recruitment by human mast cell tryptase. , 1995, International archives of allergy and immunology.

[21]  L. Schwartz,et al.  Evaluation of human peripheral blood leukocytes for mast cell tryptase. , 1987, Journal of immunology.

[22]  G. Rajka,et al.  Diagnostic Features of Atopic Dermatitis , 1980, Acta Dermato-Venereologica.

[23]  J. Ring,et al.  Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. , 1997, Dermatology.

[24]  P. Dowd,et al.  The new H1 antihistamines. Treatment of urticaria and other clinical problems. , 1993, Dermatologic clinics.

[25]  L. Schwartz,et al.  Tryptase from human mast cells: biochemistry, biology and clinical utility. , 1990, Monographs in allergy.